Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: New York NY, Morristown NJ, Valhalla NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: New York NY, East Brunswick NJ, Fairfax VA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase2, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: New York NY, Morristown NJ, Baltimore MD, Boston MA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase3, Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for
Lymphoma
Location: New York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07015242
Phase2, Recruiting
Study of GS-2426 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New York NY, East Brunswick NJ, Grand Rapids MI,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07601243
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Hackensack NJ, New York NY, New Haven CT, Boston MA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Lake Success NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: The Bronx NY, New Brunswick NJ, Burlington MA,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients